MSB 4.07% $1.15 mesoblast limited

Ryoncil: ODAC/FDA Meeting Discussion, page-1994

  1. 7,383 Posts.
    lightbulb Created with Sketch. 1920
    I think SI is more than happy to conduct the extension trial together with the FDA.

    Yes. As mentioned in this morning's phone conference, MSB will conduct an adult RCT against the current best treatment available (i.e. ruxolitinib). This is going to hurt the competition some more.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.15
Change
0.045(4.07%)
Mkt cap ! $1.313B
Open High Low Value Volume
$1.08 $1.16 $1.08 $4.681M 4.170M

Buyers (Bids)

No. Vol. Price($)
1 99680 $1.15
 

Sellers (Offers)

Price($) Vol. No.
$1.16 31000 2
View Market Depth
Last trade - 16.10pm 19/07/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.